Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2021

View Archived Issues

4-PBA and TUDCA reduce symptoms in murine model of Alport syndrome

ADAMTS15 genetic variation causes hand and feet contractures without palmar creases

Neurons derived from iPSCs capture encoded genetic risk for Alzheimer's disease

New DGAT-2 inhibitors discovered at Inorbit Therapeutics

Boehringer Ingelheim describes new plasma kallikrein inhibitors

Monoglyceride lipase inhibitors identified at Janssen

Curadev Pharma presents new STING antagonists

Anti-VISTA antibody PMC-309 shows antitumor activity in vivo

ZEN-3694 reverses acquired resistance to CDK4/6 inhibitors in ER+ breast cancer

AI-driven discovery of novel candidates for idiopathic pulmonary fibrosis

IL-21 and IL-6 predict clinical worsening in patients with COVID-19

Analysis boosts genomics-driven precision medicine

Discovery of novel new anti-cryptosporidial lead, SLU-2633

NeuExcell, Spark Therapeutics enter collaboration to develop gene therapy for Huntington's disease

CRP, ferritin and D-dimer as biomarkers for predicting COVID-19 pneumonia progression

BCL7A predicts outcome in glioma patients

In vitro lung models of COVID-19 developed using stem cell-derived human lung organoids

Insilico Medicine and University of Cambridge collaborate on protein liquid-liquid phase separation

Adaptimmune and Genentech collaborate on allogeneic cell therapies for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...